about
Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: a review of data from prospective, randomised studies.Vasopressor Use for Severe Hypotension-A Multicentre Prospective Observational Study.Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysisThe pain, agitation, and delirium practice guidelines for adult critically ill patients: a post-publication perspectiveVariation in diurnal sedation in mechanically ventilated patients who are managed with a sedation protocol alone or a sedation protocol and daily interruption.Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.Alcohol, nicotine, and iatrogenic withdrawals in the ICU.Why Candida sepsis should matter to ICU physicians.Workplace Blame and Related Concepts: An Analysis of Three Case Studies.Worldwide Survey of the "Assessing Pain, Both Spontaneous Awakening and Breathing Trials, Choice of Drugs, Delirium Monitoring/Management, Early Exercise/Mobility, and Family Empowerment" (ABCDEF) Bundle.The intensive care delirium research agenda: a multinational, interprofessional perspective.One-Year Outcomes in Caregivers of Critically Ill Patients.Analgesia in Neurocritical Care: An International Survey and Practice Audit.Effectiveness and Safety of an Extended ICU Visitation Model for Delirium Prevention: A Before and After Study.Prevalence, risk factors, and outcomes associated with physical restraint use in mechanically ventilated adults.The RECOVER Program: Disability Risk Groups & One Year Outcome after ≥ 7 Days of Mechanical Ventilation.Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial.Recall of ICU Stay in Patients Managed With a Sedation Protocol or a Sedation Protocol With Daily Interruption.Post-intensive care cognitive impairment: questions in mind?The accurate recognition of delirium in the ICU: the emperor's new clothes?Critically ill patients and end-of-life decision-making: the senior medical resident experience.Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis.Can critical-care delirium be treated pharmacologically?The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trial.I-SAVE study: impact of sedation, analgesia, and delirium protocols evaluated in the intensive care unit: an economic evaluation.In medical-surgical ICU patients, major bleeding is common but independent of heparin prophylaxis.Enhancing the informed consent process for critical care research: strategies from a thromboprophylaxis trial.Pharmacological management of sedation and delirium in mechanically ventilated ICU patients: remaining evidence gaps and controversies.Improving partnerships with family members of ICU patients: study protocol for a randomized controlled trial.The Evidence to Use Antipsychotics to Prevent or Treat Delirium Remains Sparse.To Sleep, Perhaps to Dream: Sedatives and the Uncertainties Surrounding Therapeutic Choices in Critical Care.Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors.Recognition and labeling of delirium symptoms by intensivists: does it matter?The kynurenine pathway: a metabolinomic pathway for intensive care unit delirium?*.Delirium Assessment Tools for Use in Critically Ill Adults: A Psychometric Analysis and Systematic Review.Clinician perspectives on protocols designed to minimize sedation.Electrical impedance tomography's correlation to lung volume is not influenced by anthropometric parameters.Trials of statins in delirium-stymied by complex methods?Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial.
P50
Q30572188-EAAFD797-5DD4-4B7C-932D-1CF1AE96B267Q36255350-893B0B68-572C-49B9-A93C-F78D02D8AAFCQ36655652-4674AA4A-CDB8-4E19-AD31-03C8A8FFEB11Q36705796-2EFAFF5D-94E6-452D-A057-4041B6001BBEQ36755545-990EA4B2-2525-4DA6-8DA5-B11174F404B2Q37142026-AA0FFC9F-F76A-4532-98DB-60AB081C2656Q38069913-A8200BF7-F25D-4966-9622-F72731BD0F05Q38132574-6176E9B0-30FB-47F5-8DE4-CB1F69FDA865Q38149370-80598F25-EF31-4AB6-85A5-62B8485D8167Q38451342-969060A4-D288-457D-83B5-B96625A4CB26Q38634769-0BC228E4-F90E-4481-9DE9-70BB92740EEFQ39371231-A1E539BC-0750-4950-931A-CEC284D0A223Q39774852-C2E5605E-188C-4562-B6D5-C85842FA2F6BQ39915227-BB8B52D8-2E51-4401-948A-D504FC72DA43Q40149274-1A4B241C-F71F-48DC-936C-503587187CE1Q40406126-2460D340-05BD-4D8D-BB26-45AF4DC1D32CQ40855456-04E2588A-4561-4C95-AA5D-28A9B488E3E3Q40901540-67F0EAF7-F9B9-4669-ADEA-63595708C92CQ41580890-D8E10967-1D35-4560-A165-4BB533392807Q44168750-C8821A97-CEB7-43B9-9EAB-ECFED5DAE60EQ44171836-44F8C336-9F27-4B7B-B4CE-F0F12C4E0BB0Q44309927-C08CB80F-3D55-4FE3-976A-E1E1B0F83FF0Q44316500-A6C5CC4D-AF32-4F34-AA09-6896889A52E6Q44777244-E6EFB409-7902-4A36-8870-B12F991736B0Q45297614-0D2B4552-C790-483F-B4B7-05E60FCC1297Q45812471-97407BFD-BAA9-4532-A014-0499657F92C8Q45933945-E95EB901-46AA-4C86-B22E-BD633C16B161Q45983861-EA0E7272-91F8-4267-B17E-7CADCCDC1BDFQ46858123-64CA035F-6426-4A98-99A1-ADD51F3DFB8EQ47098785-0D3A9121-1DA7-4BC1-8765-4544E8B720ABQ47805448-FE1CDCF3-16AF-4E24-90A3-2B2DD0DFCC30Q47847877-1DA5BF49-3AD2-4460-ACA5-070F3A6D862FQ48092301-DC6C67EA-4CBC-4E41-871B-9259D59FEA5AQ48448148-F9E1B35D-FB04-4248-95B2-D040900E846FQ48654913-F2400F6E-987F-4FDE-93B3-173435B6F92FQ50046064-AE7DFB73-7960-4543-8BD8-45B8506EE2D6Q50618060-2457920B-46EA-4860-B353-81921E71DAD3Q51805863-4755A09F-08D3-4BA2-876A-E27DF3E4202CQ52566962-624AE4BF-C8A2-44B3-B22C-0ABCC3486888Q52803201-9FB76C8A-D747-4D68-8398-8000BC97A105
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yoanna Skrobik
@ast
Yoanna Skrobik
@en
Yoanna Skrobik
@es
Yoanna Skrobik
@nl
type
label
Yoanna Skrobik
@ast
Yoanna Skrobik
@en
Yoanna Skrobik
@es
Yoanna Skrobik
@nl
prefLabel
Yoanna Skrobik
@ast
Yoanna Skrobik
@en
Yoanna Skrobik
@es
Yoanna Skrobik
@nl
P106
P31
P496
0000-0002-5315-6020